Barley sprouts are 5 to 20 day-old grown whole plants that are widely consumed as a functional vegetable due to their health-promoting compounds such as saponarin, γ -Aminobutyric acid (GABA), and policosanols. Recent plasma applications have been a promising approach in the agricultural and food industries to produce bioactive phytochemicals in sprouted crops. Therefore, this study investigated the plasma effects on the whole plant and its bioactive phytochemicals compared with those of an untreated control in barley sprouts. The optimal plasma exposure during seed germination can change physical and chemical properties of fully hydrated seeds of barley, accelerate the early growth of its sprouts and enhance bioactive phytochemicals in the sprouts. Thus, a single 6 min exposure of the plasma enhanced the fresh weight of whole barley seedlings by 137.5% of the untreated control at 9 d after the exposure and enhanced the contents of the primary metabolites including soluble sugars and free amino acids, and secondary metabolites including special phytochemicals such as saponarin, GABA, and policosanols. Therefore, our results suggest that the optimal plasma exposure can be used as a promising seed priming technique for the whole plant and the bioactive phytochemicals of barley sprouts.

Osteoporosis is frequently induced following menopause, and bone fractures result in serious problems including skeletal deformity, pain, and increased mortality. Therefore, safe and effective therapeutic agents are needed for osteoporosis. This study aimed to clarify the bone protecting effects of germinated soy germ extracts (GSGE) and their mode of action. GSGE increased expression of alkaline phosphatase (ALP) and osteocalcin (OCL) by stimulating the expression of runt-related transcription factor 2 (Runx2) and osterix (Osx) through activation of Smad signaling molecules. Furthermore, germination of soy germ increased levels of nutritional components, especially soyasaponin Ab. The anabolic activity of soyasaponin Ab in GSGE was also evaluated. GSGE and soyasaponin Ab significantly protected against ovariectomy (OVX)-induced bone loss and improved bone-specific alkaline phosphatase (BALP) level in mouse serum. Thesein vitroandin vivostudy results demonstrated that GSGE and soyasaponin Ab have potential as therapeutic candidate agents for bone protection in postmenopausal osteoporosis.